| Literature DB >> 28601330 |
Paul D DiMusto1, Brooks L Rademacher2, Jennifer L Philip2, Shahab A Akhter3, Christopher B Goodavish3, Nilto C De Oliveira3, Paul C Tang4.
Abstract
BACKGROUND: This study compares the morphology and outcomes of acute retrograde type A dissections (RTADs) with acute antegrade type A dissections (ATADs), and acute type B dissections.Entities:
Keywords: Aortic dissection; Aortic operation; Computed tomography; Outcomes
Mesh:
Year: 2017 PMID: 28601330 PMCID: PMC6942928 DOI: 10.1016/j.jss.2017.02.034
Source DB: PubMed Journal: J Surg Res ISSN: 0022-4804 Impact factor: 2.192
Fig. 1–Contrast intensity ratio at mid-descending thoracic aorta versus false lumen perfusion of aortic branches in all type A dissection.
Fig. 2–Contrast intensity ratio at mid-descending thoracic aorta versus false lumen perfusion of aortic branches in dissections with primary tears in the proximal descending thoracic aorta.
Total aortic cross-sectional area in RTAD versus ATAD.
| Aortic segment areas (mm2) | RTAD ( | ATAD ( | |
|---|---|---|---|
| Annulus | 468.75 ± 78.81 | 436.88 ± 133.80 | 0.18 |
| Root | 1255.92 ± 465.15 | 1613.72 ± 711.84 | 0.04 |
| Ascending aorta | 1694.92 ± 490.85 | 1954.83 ± 705.73 | 0.34 |
| Proximal arch | 1346.58 ± 329.62 | 1412.64 ± 541.01 | 0.95 |
| Distal arch | 956.25 ± 290.31 | 782.09 ± 226.15 | 0.02 |
| Mid-descending thoracic | 803.00 ± 211.12 | 664.20 ± 187.22 | 0.02 |
| Supra-celiac | 690.25 ± 106.49 | 592.61 ± 246.30 | 0.01 |
| Infra-renal | 449.80 ± 188.54 | 334.32 ± 137.78 | 0.02 |
Continuous data expressed as mean standard deviation. Comparisons calculate using the Wilcoxon rank-sum test.
True lumen area as fraction of total lumen area in RTAD versus ATAD.
| Aortic segment | RTAD ( | ATAD ( | |
|---|---|---|---|
| Root | 0.88 ± 0.13 | 0.76 ± 0.22 | 0.11 |
| Ascending aorta | 0.50 ± 0.21 | 0.38 ± 0.28 | 0.03 |
| Proximal arch | 0.54 ± 0.13 | 0.46 ± 0.22 | 0.04 |
| Distal arch | 0.50 ± 0.19 | 0.62 ± 0.28 | 0.13 |
| Mid-descending thoracic | 0.45 ± 0.21 | 0.62 ± 0.32 | 0.09 |
| Supra-celiac | 0.49 ± 0.29 | 0.63 ± 0.34 | 0.28 |
| Infra-renal | 0.65 ± 0.32 | 0.71 ± 0.38 | 0.53 |
Continuous data expressed as mean standard deviation. Comparisons calculate using the Wilcoxon rank-sum test.
Fig. 3–Anatomic depiction of the morphologic differences between antegrade type A, retrograde type A and type B dissections.
Patient demographics in RTAD versus ATAD.
| Variable | RTAD ( | ATAD ( | |
|---|---|---|---|
| Age (y) | 59.0 ± 12.9 | 60.3 ± 15.5 | 0.68 |
| Sex (male) | 8 (66.7%) | 67 (69.8%) | 0.82 |
| Weight (kg) | 94.6 ± 14.7 | 88.5 ± 24.3 | 0.12 |
| Height (cm) | 174.6 ± 11.2 | 174.1 ± 10.6 | 0.97 |
| Preoperative creatinine (mg/dL) | 1.21 ± 0.45 | 1.12 ± 0.43 | 0.42 |
| Ejection fraction (%) | 61.5 ± 3.4 | 57.6 ± 9.8 | 0.21 |
| Hypertension | 9 (75.0%) | 65 (67.7%) | 0.61 |
| Cerebrovascular disease | 1 (8.3%) | 5 (5.2%) | 0.66 |
| Peripheral vascular disease | 2 (16.7%) | 17 (17.7%) | 0.93 |
| Lung disease | 2 (16.7%) | 15 (15.6%) | 0.92 |
| Liver disease | 0 (0%) | 2 (2.1%) | 0.61 |
| Diabetes | 1 (8.3%) | 6 (6.2%) | 0.78 |
| Hyperlipidemia | 7 (58.3%) | 43 (44.8%) | 0.38 |
| Cancer within 5 y of surgery | 0 (0%) | 3 (3.1%) | 0.53 |
All nominal data expressed as n and percentage of total population and compared with Pearson χ2 or Fisher’s exact test. Continuous data expressed as mean ± standard deviation with comparisons calculated using the Wilcoxon rank-sum test.
Presentation and operative parameters.
| Variable | RTAD ( | ATAD ( | |
|---|---|---|---|
| Cardiogenic shock on presentation | 1 (8.3%) | 8 (8.3%) | 1.00 |
| Malperfusion on presentation | 2 (16.7%) | 14 (14.6%) | 0.85 |
| Operation year | 2014 (4, 2011–2015) | 2012 (5, 2009–2014) | 0.13 |
| Redo surgery | 0 (0%) | 8 (8.3%) | 0.30 |
| AV resuspension | 12 (100%) | 71 (74.0%) | 0.04 |
| CVG | 0 (0%) | 19 (19.8%) | 0.09 |
| AVR | 0 (0%) | 5 (5.2%) | 0.42 |
| VSR | 0 (0%) | 1 (1.0%) | 0.72 |
| CABG | 1 (8.3%) | 2 (2.1%) | 0.21 |
| Mitral valve surgery | 0 (0%) | 0 (0%) | 0 |
| Tricuspid valve surgery | 0 (0%) | 0 (0%) | 0 |
| Ascending aortic replacement only | 5 (41.7%) | 54 (56.2%) | 0.34 |
| Ascending and hemiarch replacement | 7 (58.3%) | 36 (37.5%) | 0.16 |
| Ascending and total arch replacement | 0 (0%) | 6 (6.2%) | 0.37 |
| Cardiopulmonary bypass time (min) | 270.67 ± 84.25 | 267.26 ± 96.75 | 0.83 |
| Cross-clamp time (min) | 82.50 ± 22.40 | 108.41 ± 47.59 | 0.07 |
| Circulatory arrest (min) | 40.92 ± 8.02 | 33.66 ± 15.02 | 0.01 |
AV = aortic valve; AVR = aortic valve replacement; CABG = coronary artery bypass grafting; CVG = composite valve graft; VSR = valve sparing root replacement.
Median, first quartile-third quartile. All nominal data expressed as n and percentage of total population and compared with Pearson χ2 or Fisher’s exact test. Continuous data expressed as mean standard deviation with comparisons calculated using the Wilcoxon rank-sum test. Year of operation is expressed as median with interquartile range and analyzed with median test.
Postoperative outcomes.
| Variable | RTAD ( | ATAD ( | |
|---|---|---|---|
| Neurologic events | 1 (8.3%) | 11 (11.4%) | 0.74 |
| Pneumonia | 1 (8.3%) | 10 (10.4%) | 0.82 |
| Prolonged ventilation | 6 (50.0%) | 58 (60.4%) | 0.49 |
| Gastrointestinal | 0 (0%) | 6 (6.2%) | 0.37 |
| Acute renal failure | 2 (16.7%) | 10 (10.4%) | 0.52 |
| Surgery to discharge (d) | 11.42 ± 7.39 | 10.52 ± 17.27 | 0.31 |
All nominal data expressed as n and percentage of total population and compared with Pearson χ2 or Fisher’s exact test. Continuous data expressed as mean ± standard deviation with comparisons calculated with the Wilcoxon rank-sum test.